Introducing Dr Rebecca Deans Country Representative Sydney-based fertility specialist Dr Rebecca Deans is the new ASPIRE country representative for Australia succeeding Professor Louise Hull. Rebecca completed her medical training at Sydney University. She went on to pursue speciality training in obstetrics and gynaecology and subsequently developed an interest in the sub-specialty area of reproductive [...]
A serious decline in world population numbers and its major economic and social ramifications in coming decades can be addressed by recognition of the lifelong benefits generated by children born from assisted reproduction. This was the thrust of the 2022 ASPIRE Congress Bruno Lunenfeld Lecture by eminent reproductive specialist, Professor David Adamson, who said [...]
ASPIRE’s education and accreditation program this year has provided a range of important professional development and certification opportunities for members. Dr Virgilio Novero, Chair of ASPIRE’s Education Committee, said the program in part had been developed collaboratively with Special Interest Groups (SIGs) and other organisations with valued support from the pharmaceutical industry. ASPIRE’s Accreditation [...]
Despite ongoing impacts of COVID-19 variants around the world, we are all working hard to emerge from the pandemic with an optimistic outlook. For members of ASPIRE eager to return to the traditional companionship and collegiality of our annual congresses, the future looks far brighter than it has for the past couple of years. [...]
The 2023 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) will burst back to a face-to-face format in the wake of COVID-19 restrictions with South Australia’s capital city Adelaide to host the event. The Congress will be presented at the Adelaide Convention Centre from 7 to 10 September next year addressing the theme [...]
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress The 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) put delegates from 43 countries at the vanguard of scientific research and medical practice in the diagnosis and treatment of human infertility. Presented in virtual format because of on-going COVID-19 issues, the Congress from 28 [...]
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress A global review of the effects of COVID-19 on pregnancy and the fetus has cast new light on the importance of improving the low uptake of coronavirus vaccination to protect pregnant women and their babies in the on-going pandemic. Reproductive medicine specialists from more than 100 [...]
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress SINGAPORE: The aftermath of the COVID-19 pandemic is expected to have major impacts on the nature of cross border reproductive care where infertile couples and individuals in the past travelled extensively abroad to access medically assisted conception. The 2022 Congress of the Asia Pacific Initiative on [...]
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress SINGAPORE: Leaders in reproductive medicine from more than 100 countries were today urged to help prevent women suffering from the debilitating effects of endometriosis from embarking on “diagnostic misadventures.” Speaking at the 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE), Professor Hugh Taylor, an [...]
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress Male infertility factors are emerging as likely biomarkers for later life health events including hospital treatments and possible premature death from conditions such as cancer, cardiovascular and metabolic diseases. Lifestyle and social factors, including partner and child relationships, may also be intertwined in the fertility status [...]
